Description
VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE UNUSED FY24 FUNDS FOR NJ.
Base award description: VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-01-23+$995,668= $995,668
- Mod P000022025-08-12-$85,753= $909,915
- Mod P000032025-12-18-$1,286= $908,629
- Mod P000042026-01-07-$533= $908,096
- Mod P000052026-01-14-$106,288= $801,808
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-01-23 | +$995,668 | $995,668 | VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2025-08-12 | −$85,753 | $909,915 | VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE UNUSED FY24 FUNDS. |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2025-12-18 | −$1,286 | $908,629 | VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE UNUSED FY24 FUNDS. |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-01-07 | −$533 | $908,096 | VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE UNUSED FY24 FUNDS. |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2026-01-14 | −$106,288 | $801,808 | VISN 2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS - MODIFICATION TO DE-OBLIGATE UNUSED FY24 FUNDS FOR NJ. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQAKL78AXMT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0481 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $3,356,110 | FY2026 |
| 36C24426P0225 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $148,383 | FY2026 |
| 36C24226D0037 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24226N0381 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $959,170 | FY2026 |
| 36C24425N0451 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $180,327 | FY2025 |
| 36C24225N0386 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $330,602 | FY2025 |
Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226P0942 | PRIORITY HEALTHCARE DISTRIBUTION INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $15,746 | FY2026 |
| 36C24226P0910 | THERACOM, L.L.C. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $39,143 | FY2026 |
| 36C24226P0901 | COVERMYMEDS PHARMACY LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $16,331 | FY2026 |
| 36C24226P0895 | CARDINAL HEALTH 108, LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $31,219 | FY2026 |
| 36C24226P0900 | COVERMYMEDS PHARMACY LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $11,315 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24224N0262_3600_36C24223D0045_3600 · retrieved 2026-09-26.